{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T13:28:39Z","timestamp":1762176519437},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2011,5,12]],"date-time":"2011-05-12T00:00:00Z","timestamp":1305158400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[2011,11]]},"DOI":"10.1007\/s00228-011-1045-0","type":"journal-article","created":{"date-parts":[[2011,5,11]],"date-time":"2011-05-11T11:51:17Z","timestamp":1305114677000},"page":"1169-1174","source":"Crossref","is-referenced-by-count":16,"title":["Plenty of pills: polypharmacy prevails in patients of a Danish anticoagulant clinic"],"prefix":"10.1007","volume":"67","author":[{"given":"Jane","family":"Skov","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Else-Marie","family":"Bladbjerg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johannes","family":"Sidelmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marianne","family":"Vamosi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00f8rgen","family":"Jespersen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,5,12]]},"reference":[{"key":"1045_CR1","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1161\/01.CIR.0000145172.55640.93","volume":"110","author":"BF Gage","year":"2004","unstructured":"Gage BF, van Walraven C, Pearce L, Hart RG, Koudstaal PJ, Boode BS, Petersen P (2004) Selecting patients with atrial fibrillation for anticoagulation: stroke risk stratification in patients taking aspirin. Circulation 110:2287\u20132292","journal-title":"Circulation"},{"key":"1045_CR2","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1093\/eurheartj\/ehq278","volume":"31","author":"AJ Camm","year":"2010","unstructured":"Camm AJ, Kirchhof P, Lip GY, Schotten U, Savelieva I, Ernst S, Van Gelder IC, Al-Attar N, Hindricks G, Prendergast B, Heidbuchel H, Alfieri O, Angelini A, Atar D, Colonna P, De CR, De SJ, Goette A, Gorenek B, Heldal M, Hohloser SH, Kolh P, Le Heuzey JY, Ponikowski P, Rutten FH (2010) Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Eur Heart J 31:2369\u20132429","journal-title":"Eur Heart J"},{"key":"1045_CR3","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1503\/cmaj.061523","volume":"176","author":"N Oake","year":"2007","unstructured":"Oake N, Fergusson DA, Forster AJ, van Walraven C (2007) Frequency of adverse events in patients with poor anticoagulation: a meta-analysis. Can Med Assoc J 176:1589\u20131594","journal-title":"Can Med Assoc J"},{"key":"1045_CR4","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1111\/j.1365-2796.2005.01605.x","volume":"259","author":"AM Njaastad","year":"2006","unstructured":"Njaastad AM, Abildgaard U, Lassen JF (2006) Gains and losses of warfarin therapy as performed in an anticoagulation clinic. J Intern Med 259:296\u2013304","journal-title":"J Intern Med"},{"key":"1045_CR5","first-page":"1060","volume":"86","author":"C Manotti","year":"2001","unstructured":"Manotti C, Moia M, Palareti G, Pengo V, Ria L, Dettori AG (2001) Effect of computer-aided management on the quality of treatment in anticoagulated patients: a prospective, randomized, multicenter trial of APROAT (Automated PRogram for Oral Anticoagulant Treatment). Haematologica 86:1060\u20131070","journal-title":"Haematologica"},{"key":"1045_CR6","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1016\/S0140-6736(98)04147-6","volume":"352","author":"L Poller","year":"1998","unstructured":"Poller L, Shiach CR, MacCallum PK, Johansen AM, Munster AM, Magalhaes A, Jespersen J (1998) Multicentre randomised study of computerised anticoagulant dosage. European Concerted Action on Anticoagulation. Lancet 352:1505\u20131509","journal-title":"Lancet"},{"key":"1045_CR7","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1111\/j.1538-7836.2008.02959.x","volume":"6","author":"L Poller","year":"2008","unstructured":"Poller L, Keown M, Ibrahim S, Lowe G, Moia M, Turpie AG, Roberts C, van den Besselaar AM, van der Meer FJ, Tripodi A, Palareti G, Shiach C, Bryan S, Samama M, Burgess-Wilson M, Heagerty A, Maccallum P, Wright D, Jespersen J (2008) An international multicenter randomized study of computer-assisted oral anticoagulant dosage vs. medical staff dosage. J Thromb Haemost 6:935\u2013943","journal-title":"J Thromb Haemost"},{"key":"1045_CR8","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1503\/cmaj.070186","volume":"177","author":"JA Delaney","year":"2007","unstructured":"Delaney JA, Opatrny L, Brophy JM, Suissa S (2007) Drug\u2013drug interactions between antithrombotic medications and the risk of gastrointestinal bleeding. Can Med Assoc J 177:347\u2013351","journal-title":"Can Med Assoc J"},{"key":"1045_CR9","first-page":"24","volume":"6","author":"RA Sansone","year":"2009","unstructured":"Sansone RA, Sansone LA (2009) Warfarin and Antidepressants: Happiness without Hemorrhaging. Psychiatry (Edgmont) 6:24\u201329","journal-title":"Psychiatry (Edgmont)"},{"key":"1045_CR10","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1046\/j.0306-5251.2001.01469.x","volume":"52","author":"A Fugh-Berman","year":"2001","unstructured":"Fugh-Berman A, Ernst E (2001) Herb-drug interactions: review and assessment of report reliability. Br J Clin Pharmacol 52:587\u2013595","journal-title":"Br J Clin Pharmacol"},{"key":"1045_CR11","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1111\/j.1365-2141.2005.05689.x","volume":"130","author":"NA Ramsay","year":"2005","unstructured":"Ramsay NA, Kenny MW, Davies G, Patel JP (2005) Complimentary and alternative medicine use among patients starting warfarin. Br J Haematol 130:777\u2013780","journal-title":"Br J Haematol"},{"key":"1045_CR12","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1001\/archinte.165.10.1095","volume":"165","author":"AM Holbrook","year":"2005","unstructured":"Holbrook AM, Pereira JA, Labiris R, McDonald H, Douketis JD, Crowther M, Wells PS (2005) Systematic overview of warfarin and its drug and food interactions. Arch Intern Med 165:1095\u20131106","journal-title":"Arch Intern Med"},{"key":"1045_CR13","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1503\/cmaj.070946","volume":"177","author":"DN Juurlink","year":"2007","unstructured":"Juurlink DN (2007) Drug interactions with warfarin: what clinicians need to know. Can Med Assoc J 177:369\u2013371","journal-title":"Can Med Assoc J"},{"key":"1045_CR14","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1160\/TH04-02-0109","volume":"92","author":"HH Thijssen","year":"2004","unstructured":"Thijssen HH, Soute BA, Vervoort LM, Claessens JG (2004) Paracetamol (acetaminophen) warfarin interaction: NAPQI, the toxic metabolite of paracetamol, is an inhibitor of enzymes in the vitamin K cycle. Thromb Haemost 92:797\u2013802","journal-title":"Thromb Haemost"},{"key":"1045_CR15","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1160\/TH08-10-0664","volume":"101","author":"L Poller","year":"2009","unstructured":"Poller L, Keown M, Ibrahim S, Lowe G, Moia M, Turpie AG, Roberts C, van den Besselaar AM, van der Meer FJ, Tripodi A, Palareti G, Shiach C, Bryan S, Samama M, Burgess-Wilson M, Heagerty A, Maccallum P, Wright D, Jespersen J (2009) A multicentre randomised assessment of the DAWN AC computer-assisted oral anticoagulant dosage program. Thromb Haemost 101:487\u2013494","journal-title":"Thromb Haemost"},{"key":"1045_CR16","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1160\/TH05-03-0166","volume":"94","author":"C Gasse","year":"2005","unstructured":"Gasse C, Hollowell J, Meier CR, Haefeli WE (2005) Drug interactions and risk of acute bleeding leading to hospitalisation or death in patients with chronic atrial fibrillation treated with warfarin. Thromb Haemost 94:537\u2013543","journal-title":"Thromb Haemost"},{"key":"1045_CR17","first-page":"A4165","volume":"57","author":"K Schaefer","year":"2010","unstructured":"Schaefer K, Maerkedahl H, Birk HO, Henriksen LO (2010) Polypharmacy in general practice. Dan Med Bull 57:A4165","journal-title":"Dan Med Bull"},{"key":"1045_CR18","doi-asserted-by":"crossref","first-page":"141","DOI":"10.2165\/00002512-199914020-00005","volume":"14","author":"PA Atkin","year":"1999","unstructured":"Atkin PA, Veitch PC, Veitch EM, Ogle SJ (1999) The epidemiology of serious adverse drug reactions among the elderly. Drugs Aging 14:141\u2013152","journal-title":"Drugs Aging"},{"key":"1045_CR19","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1046\/j.1532-5415.2002.50607.x","volume":"50","author":"G Onder","year":"2002","unstructured":"Onder G, Pedone C, Landi F, Cesari M, Della VC, Bernabei R, Gambassi G (2002) Adverse drug reactions as cause of hospital admissions: results from the Italian Group of Pharmacoepidemiology in the Elderly (GIFA). J Am Geriatr Soc 50:1962\u20131968","journal-title":"J Am Geriatr Soc"},{"key":"1045_CR20","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1056\/NEJMoa0809329","volume":"360","author":"TE Klein","year":"2009","unstructured":"Klein TE, Altman RB, Eriksson N, Gage BF, Kimmel SE, Lee MT, Limdi NA, Page D, Roden DM, Wagner MJ, Caldwell MD, Johnson JA (2009) Estimation of the warfarin dose with clinical and pharmacogenetic data. N Engl J Med 360:753\u2013764","journal-title":"N Engl J Med"},{"key":"1045_CR21","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1093\/gerona\/61.5.511","volume":"61","author":"JT Hanlon","year":"2006","unstructured":"Hanlon JT, Pieper CF, Hajjar ER, Sloane RJ, Lindblad CI, Ruby CM, Schmader KE (2006) Incidence and predictors of all and preventable adverse drug reactions in frail elderly persons after hospital stay. J Gerontol A Biol Sci Med Sci 61:511\u2013515","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"1045_CR22","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1592\/phco.24.17.1668.52338","volume":"24","author":"AK Wittkowsky","year":"2004","unstructured":"Wittkowsky AK, Boccuzzi SJ, Wogen J, Wygant G, Patel P, Hauch O (2004) Frequency of concurrent use of warfarin with potentially interacting drugs. Pharmacotherapy 24:1668\u20131674","journal-title":"Pharmacotherapy"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-011-1045-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00228-011-1045-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-011-1045-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,10]],"date-time":"2019-06-10T14:33:09Z","timestamp":1560177189000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00228-011-1045-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5,12]]},"references-count":22,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2011,11]]}},"alternative-id":["1045"],"URL":"https:\/\/doi.org\/10.1007\/s00228-011-1045-0","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"value":"0031-6970","type":"print"},{"value":"1432-1041","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,5,12]]}}}